SavedAdd your journal

Journals / Turkish Journal of Medical Sciences / 2005 / Cilt: 35 - Sayı: 6

Megadose Methylprednisolone for Childhood Idiopathic Trombocytopenic Purpura (ITP)

Şinasi ÖZSOYLU
Pages
347–356
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

For oral MDMP treatment, admission of the patients is not required and there is some evidence that chronic ITP could be prevented by this approach.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Idiopathic thrombocytopenic purpura (ITP) is an autoimmune disorder.
📊
Key Findings & Data:Decreased platelet survival is the main pathogenesis, which is related to platelet antibodies (APA).
💡
Conclusion & Impact:For oral MDMP treatment, admission of the patients is not required and there is some evidence that chronic ITP could be prevented by this approach.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Mega dose methylprednisolone · idiopathic trombocytopenic purpura · Mega dose methylprednisolone

Abstract

Idiopathic thrombocytopenic purpura (ITP) is an autoimmune disorder. Decreased platelet survival is the main pathogenesis, which is related to platelet antibodies (APA). The levels of these antibodies are correlated with relapse and remission which was shown for the first time by our group. Although APA levels decrease in remission they do not disappear as we have shown. Among the several appraches to ITP treatment, oral megadose methylprednisolone is found to be the cheapest and most effective one. For oral MDMP treatment, admission of the patients is not required and there is some evidence that chronic ITP could be prevented by this approach.

Özet

Idiopathic thrombocytopenic purpura (ITP) is an autoimmune disorder. Decreased platelet survival is the main pathogenesis, which is related to platelet antibodies (APA). The levels of these antibodies are correlated with relapse and remission which was shown for the first time by our group. Although APA levels decrease in remission they do not disappear as we have shown. Among the several appraches to ITP treatment, oral megadose methylprednisolone is found to be the cheapest and most effective one. For oral MDMP treatment, admission of the patients is not required and there is some evidence that chronic ITP could be prevented by this approach.

🔖

Cite This Article

ÖZSOYLU, Ş. (2022). Megadose Methylprednisolone for Childhood Idiopathic Trombocytopenic Purpura (ITP). Turkish Journal of Medical Sciences, Cilt: 35 - Sayı: 6, 347–356. https://ajindex.com/articles/611963

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Branehög I.Platelet kinetics in idiopathic thrombcoytopenic purpura (ITP) before and at different times after splenectomy. Br J Haematol 29:413-418,1975.
  2. Harrington WJ, Minnich V, Hollings wath JW et al. Demonstration of a thrombocytopenia factor in the blood of patients with thrombocytopenic purpura. J Lab Clin Med 38:1-9,1951.
  3. Özsoylu fi, Irken G, Karabent A. High-dose intravenous methylprednisolone for acute childhood idiopathic thrombocytopenic purpura. Eur J Haematol 42:431-435, 1989. Schwartz AD. A method for demonstrating shortened platelet survival recovery from asprin effect. J Pediatr 84:350, 1974. McClure PD. Idiopathic thromboyctopenic purpura in children. Should corticosteroid be given. Am J dis Child 131:357- 359,1977.
  4. Zuelzer WW, Lusher JM. Childhood idiopathic thrombocytopenic purpura. To treat or not to treat. Am J Dis Child 131:360- 362,1977.
  5. Imbach P, Wagner HP, Berithold W et al. Intravenous immunoglobulin versus corticosteroid in acute immune thrombcytopenic purpura in childhood. Lancet 2:464-468,1985.
  6. Ryan ME, Webster ML: Adverse effects of intravenous immunglobulin therapy. Clin Pediatr 35: 23-28,1996.
  7. Brecher G, Cronkite EP. Morphology and enumeration of human blood platelets. J Appl Physiol 3:365-377,1951.
  8. Özsoylu fi, Ertürk G. Oral megadose methylprednisolone for childhood acute idiopathic thrombocytopenic purpura. Blood 77:1856-1857,1991
  9. Özsoylu fi, Saylı T, Ertürk G. Oral megadose methylprednisolone versus intravenous immunglobulin for acute childhood acute idiopathic thrombocytopenic purpura. Pediatr Hematol Oncol 10:317-321,1993. Özsoylu fi. Bolus methylprednisolone therapy in chronic idiopathic thrombocytopenic purpura in children. Acta Haematol 72:359,1984. Özsoylu fi. High dose intravenous methylprednisolone for chronic idiopathic thrombocytopenic purpura. Acta Haematol 81:112- 113,1989.
  10. Akoğlu T, Paydafl ?, Bayık M et al. Megadose methylprednisolone pulse therapy in adult idiopathic thrombocytopenic purpura in adults. Lancet 337:56,1991. Manoharan A. Treatment of refractory idiopathic thrombocytopenic purpura in adults. Br J Haematol 79:143, 1991. Özsoylu fi. Nose drops and the common cold. Eur J Pediatr 144:294,1985.
  11. Bernini JC, Carillo JM, Buchanon GR. High-dose intravenous methylprednisolone therapy for patient with Diamond –Blackfan anemia refractory to conventional doses of prednisone. J Pediatr 127:654-659, 1995.
  12. Öztürk G, Özsoylu fi. Megadose methylprednisolone for a corticosteroid induced diabetic patient with apla